BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30919712)

  • 1. The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling.
    O'Connor SM; Lietzan E
    Am Univ Law Rev; 2019; 68(3):823-925. PubMed ID: 30919712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blurred boundaries: the therapeutics and politics of medical marijuana.
    Bostwick JM
    Mayo Clin Proc; 2012 Feb; 87(2):172-86. PubMed ID: 22305029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FDA: is it protecting the public with one hand tied behind its back?
    Shedlin RS
    Law Med Health Care; 1992; 20(3):253-7. PubMed ID: 1434771
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of drugs and devices: an evolution.
    Merrill RA
    Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. THC therapeutic research by independent and state-sponsored investigators: a historical review.
    Scigliano JA
    J Clin Pharmacol; 1981; 21(S1):113S-121S. PubMed ID: 6271816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Court decision on medical marijuana use worries patient advocates.
    Krisberg K
    Nations Health; 2005 Aug; 35(6):1,14. PubMed ID: 16130240
    [No Abstract]   [Full Text] [Related]  

  • 7. Public health issue brief: medical marijuana: year end report-2004.
    Varma P
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15765574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A death by any other name: the federal government's inconsistent treatment of drugs used in lethal injections and physician-assisted suicide.
    Miller C
    J Law Health; 2002-2003; 17(2):217-40. PubMed ID: 15853126
    [No Abstract]   [Full Text] [Related]  

  • 10. Legal and regulatory developments of the 1990s in oral care products: learning from what has come before.
    O'Reilly JT
    J Public Health Dent; 1992; 52(6):396-400. PubMed ID: 1432936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU-486: legal and policy issues confronting the Food and Drug Administration.
    Muhl C
    J Leg Med; 1993 Jun; 14(2):319-47. PubMed ID: 8340714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA policy on unapproved drug products: past, present, and future.
    Chhabra R; Kremzner ME; Kiliany BJ
    Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laetrile and the FDA: a case of reverse regulation.
    Cannizzaro JF; Rosenfeld MM
    J Health Polit Policy Law; 1978; 3(2):181-95. PubMed ID: 357475
    [No Abstract]   [Full Text] [Related]  

  • 14. Good cop, bad cop: federal prosecution of state-legalized medical marijuana use after United States v. Lopez.
    Newbern AE
    Calif Law Rev; 2000 Oct; 88(5):1575-634. PubMed ID: 11475489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jumping frogs, endangered toads, and California's medical-marijuana law.
    Annas GJ
    N Engl J Med; 2005 Nov; 353(21):2291-6. PubMed ID: 16306529
    [No Abstract]   [Full Text] [Related]  

  • 16. Readers' responses to "it is time for marijuana to be reclassified as something other than a schedule I drug".
    Alvarez L
    MedGenMed; 2005; 7(4):35; author reply 34. PubMed ID: 16671176
    [No Abstract]   [Full Text] [Related]  

  • 17. Readers' responses to "it is time for marijuana to be reclassified as something other than a schedule I drug".
    Gordon AG
    MedGenMed; 2005; 7(4):35; author reply 34. PubMed ID: 16671175
    [No Abstract]   [Full Text] [Related]  

  • 18. Readers' responses to "it is time for marijuana to be reclassified as something other than a schedule I drug".
    Gianelli PA
    MedGenMed; 2005; 7(4):35; author reply 34. PubMed ID: 16671174
    [No Abstract]   [Full Text] [Related]  

  • 19. Readers' responses to "it is time for marijuana to be reclassified as something other than a schedule I drug".
    Anderson A
    MedGenMed; 2005; 7(4):35; author reply 34. PubMed ID: 16671173
    [No Abstract]   [Full Text] [Related]  

  • 20. Readers' responses to "it is time for marijuana to be reclassified as something other than a schedule I drug".
    Verhaagh DJ
    MedGenMed; 2005; 7(4):35; author reply 34. PubMed ID: 16671172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.